Free tools Windows power users keep installed
One-click scans. No signup required.
The safest way to find a cancer vaccine clinical trial is to treat a registry result as a lead—not as proof that a study is enrolling, appropriate for your cancer, or medically advisable. Start with your oncologist, assemble precise diagnosis and treatment details, search both the National Cancer Institute (NCI) and ClinicalTrials.gov, then have the study team confirm eligibility, availability, risks, logistics, and costs.
This guide explains how to do that methodically. Trial listings and eligibility change, so verify every important detail directly with the recruiting team before making a treatment decision.
As an Amazon Associate I earn from qualifying purchases.
What “cancer vaccine” means in a clinical-trial listing
Cancer vaccine is an umbrella term, not one standardized treatment. Studies may use different targets, platforms, doses, combinations, cancer types, stages, and treatment settings. One study may test a vaccine against an existing cancer; another may investigate recurrence prevention or risk reduction. The title alone cannot tell you whether two studies are scientifically or clinically comparable.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →An NCI listing explains the distinction this way: “Unlike a standard vaccine that is used to prevent infections, cancer vaccines are being studied to see if they can fight cancers that are already in the body.” That sentence appears in the description of a specific multiple-myeloma study, so it should not be treated as a complete definition of every cancer-vaccine approach. Read the actual protocol for the study you are considering: NCI multiple-myeloma vaccine listing.
#1 Best Overall
- Read Before You Buy — No Video Output: These adapters support charging and USB 2.0 data transfer, but cannot transmit video signals. Except for standard USB webcams (which use USB data only), they are not compatible with HDMI/DisplayPort cables, video-capable USB-C hubs, or docking stations with video output.
- Convert USB-A Ports to USB-C: Designed to connect USB-C earphones, cables, flash drives, card readers, and other USB-C accessories to standard USB-A ports. Plug-and-play with no drivers or software required.
- Aluminum Alloy Housing: Built with a sturdy aluminum alloy shell that aids in heat dissipation and protects against daily wear and scratches. Designed to maintain a stable and secure connection.
- Compact & Travel-Friendly: The ultra-compact design allows the adapter to stay plugged into your device without blocking adjacent ports or adding bulk, reducing wear and tear on your original USB ports.
- 12-Month Warranty: Backed by a 12-month manufacturer warranty for peace of mind. Designed to meet strict quality control standards for reliable everyday performance.
At present, the available listings do not establish that cancer vaccines as a class work for every cancer or that any particular study is suitable for an individual. Those questions require study-specific evidence and review of your medical records.
Step 1: Prepare the information a search actually needs
Searches become more useful when you can enter the same clinical facts that appear in eligibility criteria. Ask your oncologist whether a trial search fits your situation and how much time is available before the next treatment decision. NCI’s Steps to Find a Clinical Trial page recommends working with the care team while gathering these details.
Build a personal trial-search sheet
- Diagnosis: exact cancer type, histology or subtype, and whether the disease is newly diagnosed, recurrent, refractory, locally advanced, or metastatic.
- Stage and disease setting: include current sites of disease and whether surgery, radiation, maintenance, or another setting is involved.
- Treatment history: every prior and current drug, immunotherapy, radiation course, surgery, transplant, and relevant date or reason for stopping.
- Tumor information: molecular findings, biomarkers, mutations, receptor status, or other pathology results named in your records.
- Health details: age, performance status if known, organ-function results, other conditions, medications, allergies, and recent infections.
- Practical limits: maximum travel distance, ability to attend frequent visits, work or caregiving obligations, and whether travel or temporary housing is possible.
Keep pathology reports, imaging summaries, medication lists, treatment timelines, and laboratory results together. The NCI Cancer Information Service can help organize a tailored search for discussion with your doctor; the listed U.S. number is 1-800-4-CANCER (1-800-422-6237), option 2. NCI also describes online chat and email support. Confirm current hours and contact options on its live site.
Step 2: Search more than one trial source
No single listing service contains every clinical trial. NCI’s search includes many federally supported studies, while ClinicalTrials.gov also lists cancer studies—including industry-sponsored studies—that may not appear in NCI’s collection. Use both, then verify the record with the recruiting site. NCI gives this advice in its trial-search steps.
Use NCI’s search and advanced filters
Start at NCI’s clinical-trial search and use its advanced fields for cancer type or condition, age, keywords, location, prior drugs or treatment, phase, trial ID, investigator, and lead organization. NCI’s search-form help explains that unknown or inapplicable fields should be left blank; adding more criteria reduces the number of results.
Rank #2
- 5-in-1 USB-C Hub: Experience comprehensive connectivity featuring a Power Delivery input, two USB-A 2.0 ports, a USB-A 3.0 port, and an HDMI port. (Note: The USB-C power delivery input port is only for connecting an external wall charger to power your laptop and cannot power peripheral devices.)
- 90W Pass-Through Charging: Achieve optimal charging with 90W pass-through power to your laptop, supported by a total input of 100W, with the hub reserving 10W for operational efficiency. (Note: Wall charger not included.)
- Quick Data Transfers: Accelerate your productivity with rapid data transfers using a high-speed 5Gbps USB 3.0 port and two 480Mbps USB 2.0 ports.
- 4K HDMI Display: Enhance your visual experience with a hub capable of delivering 4K resolution at 30Hz in both mirror and extend modes. Please note that this hub is compatible with MacBook (macOS 12 and newer), Windows 10 and 11, ChromeOS, and laptops equipped with DP Alt Mode and Power Delivery. Note: This device is not compatible with Linux.
- What You Get: Anker USB-C Hub (5-in-1, 4K HDMI), welcome guide, 18-month warranty, and our friendly customer service.
Search broadly before narrowing
Run separate searches for the exact cancer and subtype, then for terms associated with a known vaccine target, construct, or platform. A narrow query can miss a study because the registry uses a different synonym or groups your cancer under a broader condition. If no plausible candidates appear, remove one restriction at a time—usually a location or keyword—rather than concluding that no study exists.
On ClinicalTrials.gov, search the same diagnosis and synonyms, inspect the study’s recruitment status, and note the unique NCT identifier. A broad keyword match is only a starting point; protocol criteria determine eligibility.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Step 3: Read each record as a protocol summary
Open the full record for every plausible candidate and save or print the summary. NCI advises reviewing the purpose, eligibility, locations, contacts, and other study details before contacting the team.
Capture these fields
- Study purpose and primary outcome: what the investigators are trying to learn and how they will judge it.
- Intervention: the vaccine construct, dose or schedule when stated, and every combination treatment or control.
- Phase and design: dose-escalation, single-arm, randomized, blinded, comparative, or follow-up design.
- Recruitment status: recruiting, not yet recruiting, active but not recruiting, suspended, completed, or another label.
- Eligibility and exclusions: cancer subtype, stage, biomarkers, previous therapies, laboratory thresholds, measurable disease, age, and disqualifying conditions.
- Locations: the exact facility, city, state or country, and whether that site—not merely the overall study—is enrolling.
- Contacts: site coordinator, principal investigator, telephone number, email, sponsor, and lead organization.
- Trial identifier: NCT number or NCI study ID, which prevents confusion between similarly named studies.
Registry language can be technical. Ask your oncologist or the study contact to translate terms you do not understand. Do not infer that a listed intervention is available at every location or that a “recruiting” study can accept you immediately.
Rank #3
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
How to compare cancer-vaccine candidates
Use the same decision axes for every candidate so that an attractive title or novel platform does not outweigh a poor fit.
| Decision axis | What to check | Why it matters |
|---|---|---|
| Purpose and setting | Treatment of existing disease, recurrence prevention, risk reduction, stage, and line of therapy | Studies described as vaccines may ask fundamentally different questions. |
| Eligibility | Subtype, stage, biomarkers, age, prior treatment, laboratory values, organ function, and exclusions | Only the protocol team can determine whether your records satisfy every criterion. |
| Design and phase | Safety or dose work, activity signal, randomized comparison, control arm, combinations, and stated endpoints | Phase describes the research question; it does not guarantee benefit. |
| Burden and access | Visit frequency, scans, biopsies, blood draws, infusion time, duration, travel, lodging, childcare, and time away from work | A biologically promising study may be impractical if its schedule cannot be met. |
| Risks and alternatives | Known and unknown side effects, standard-care alternatives, other trials, and what happens if disease progresses | The relevant comparison is your realistic treatment alternatives, not another vaccine study. |
| Financial and privacy terms | Who pays for research-only procedures, routine care, travel, data handling, and treatment after withdrawal | Costs and privacy protections vary by protocol and site. |
Understand what the trial phase tells you
NCI describes phases as broad categories, but the individual protocol’s design and objectives are more informative than the phase label alone. See How Do Clinical Trials Work?
| Phase | Typical question | NCI’s illustrative enrollment range |
|---|---|---|
| Phase I | Initial safety, side effects, dose, and how the body responds | Often about 15–30 people |
| Phase II | Further safety and whether there are signs the treatment affects the cancer | Often about 50–100 people |
| Phase III | Comparison with the current standard treatment, usually in a larger population | About 100 to several thousand people |
| Phase IV | Long-term safety and effectiveness after approval | Not stated as a fixed range |
These are descriptive NCI ranges for clinical trials generally, not promises about any cancer-vaccine study. A phase I study may combine a vaccine with another therapy and may have a very different schedule from another phase I study. Ask what the control arm is, whether randomization is used, and which outcomes are primary.
Why vaccine-specific details matter
Do not transfer eligibility, expected benefit, or side effects from one vaccine study to another. Constructs can target different antigens, use different delivery platforms, and stimulate the immune system in different ways. Combination drugs may contribute substantially to both risks and outcomes.
Rank #4
- Dual Converters, Infinite Potential：Includes 2× USB C male to USB A female adapters and 2× USB A male to USB C female adapters. Perfect for a wide range of uses—tablets with Bluetooth keyboards, expand USB ports on macbook, and more. Two different converters for all your daily needs
- Next-Level 10Gbps & 3A Charging: No more slow 480Mbps, this usb to usb c adapter has a transfer speed of up to 10Gbps, allowing you to do more transferring in less time. This usb adapter fits both USB A and USB C charger, supporting up to 3A fast charging
- Upgraded Exquisite Craftsmanship: With an aluminum alloy housing and metal connector, the usbc to usb adapter is extremely durable and sturdy. Rigorously tested to withstand more than 10,000 times of plugging and unplugging, ensuring long-lasting performance
- Broad Compatible: The usb c to usb adapter widely supports all USB C/ USB A devices like laptops, tablets, cellphones, car chargers, and phone chargers. Such as compatible with MacBook Pro/Air 2023/2022, Thunderbolt 4/3 Devices,Apple MagSafe Watch 9/8/7/SE/Ultra, iPad Pro 2022/2021, Samsung Galaxy S23/S20/S10, and iPhone 17/16/15 Pro. Plug and play
- Please Note: To reach 10Gbps speed, keep the cable under 3.3 ft. For USB A Male to USB C adapters, try flipping the USB C connector. USB C Male to USB A adapters support bidirectional 10Gbps transfer within 3.3 ft
For example, an NCI-listed phase I study evaluates Ad5.F35-hGUCY2C-PADRE together with Lm-GUCY2C for locally advanced or metastatic colorectal and small-bowel cancers. Its stated focus includes side effects and dose. The record was marked active when retrieved, but current recruitment and site availability must be checked directly: NCI vaccine study listing. That example illustrates why the exact protocol—not the phrase “cancer vaccine”—should drive your evaluation.
Confirm current eligibility with the trial team
Contact the site listed for your preferred study and provide the trial identifier. Ask whether that specific site is enrolling now, whether a prescreen is available, and which records are needed. Recruitment, locations, eligibility wording, and timelines can change after a registry update.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Clear out junk files and repair common Windows errors3Fix the driver behind crashes, sound loss and screen glitches- Tell the coordinator your diagnosis, stage, key biomarkers, prior treatments, and current treatment plan.
- Ask whether your oncologist should send pathology, imaging, laboratory, or treatment records for prescreening.
- Confirm the earliest possible screening date and how long screening takes.
- Ask which tests are research-only, which are routine care, and whether a test must be repeated at the study site.
- Request the consent form and visit calendar before deciding whether travel and time commitments are manageable.
A registry match does not establish enrollment, eligibility, or medical appropriateness. Your treating clinician and the study team must review the actual record.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Evaluate risks, alternatives, costs, and your rights
NCI states, “Every clinical trial is different, which means risks can also differ.” Read the consent form and ask how known and unknown risks compare with standard treatment and with doing no immediate treatment. NCI’s guidance on treatment trials covers protocols, risks, costs, consent, and withdrawal: Participate in Cancer Treatment Trials.
Best Value
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
Costs and practical support
Ask in writing who pays for the investigational vaccine, combination drugs, routine-care visits, scans, laboratory tests, biopsies, treatment of complications, and follow-up after the study ends. NCI notes that extra visits can create travel, housing, childcare, and related expenses. Insurance rules and reimbursement differ by protocol and location; the study coordinator and your insurer can explain the specific arrangement.
Safety oversight and informed consent
Ask who monitors safety, how serious side effects are reported, when treatment would be paused, and what medical care is available for a study-related injury. NCI explains safety oversight and informed consent in Are Clinical Trials Safe? Consent should explain procedures, risks, benefits that are reasonably foreseeable, alternatives, confidentiality, costs, and contact information.
Recommended Free Tools
Leaving a study
Signing consent does not remove your choice. NCI says participants may change their mind and leave after signing. Ask what notice is requested, what safety checks are recommended, how your regular care will continue, and whether data or samples already collected can be withdrawn.
Questions to take to your oncologist and the study team
The following wording comes from NCI’s patient checklist, Questions to Ask Your Doctor About Cancer Treatment Clinical Trials. Print it with the study summary and add questions specific to your medical history.
- “Is there a clinical trial that I can join?”
- “What is the purpose of the trial?”
- “How will the doctor know if the treatment is working?”
- “How do the possible risks and benefits of this trial compare to those of the standard treatment?”
- “Will I have to pay for any of the treatments or tests?”
- “How often will I have to come to the hospital or clinic?”
Also ask what happens if your condition changes before enrollment, whether other therapies are allowed during the study, how specimens will be stored and used, and whether you can receive a copy of your signed consent form.
Quick Recap
A practical decision checklist
- Discuss timing with your oncologist. Establish whether searching now could affect a needed treatment decision.
- Complete your trial-search sheet. Verify diagnosis, stage, biomarkers, prior therapies, health information, and travel limits.
- Search NCI and ClinicalTrials.gov. Use exact and broad terms, leaving unknown fields blank.
- Shortlist by protocol, not title. Read purpose, phase, intervention, eligibility, exclusions, sites, contacts, and status.
- Compare burden and alternatives. Map visits, procedures, travel, costs, risks, standard care, and other trials.
- Prescreen with the site. Send requested records and confirm that the location is currently enrolling.
- Review consent carefully. Discuss uncertainties with your oncologist and ask for time to decide.
- Choose only after confirmation. Enrollment is a shared decision, and you retain the right to decline or withdraw.
Key takeaways
- NCI and ClinicalTrials.gov are complementary starting points; neither contains every relevant study.
- Precise diagnostic and treatment details produce more useful searches than a general “cancer vaccine” query.
- Eligibility comes from the full protocol and medical-record review, not from a keyword match.
- Phase I and II studies generally emphasize safety, dose, and early activity signals; phase III studies compare treatments; phase IV studies follow approved treatments over time.
- Vaccine targets, platforms, combinations, settings, and risks vary widely, so one study cannot stand in for another.
- Before consenting, resolve questions about risks, alternatives, costs, logistics, privacy, and withdrawal.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
